NEJM Journal Watch - General Medicine

Levetiracetam may lead to fewer rehospitalizations for seizures.

Yes! This can be a time saver in a busy clinic.

Weekly semaglutide improved overall cardiovascular outcomes in such patients, whether ejection fraction was preserved or reduced.

In a retrospective study, GLP-1 agonists were associated with slower progression to cirrhosis.

A 14-day monitor detected more atrial fibrillation but did not affect hospitalization rates for stroke or hemorrhage.

Both Cologuard Plus and Shield were approved in 2024.

Among patients with insulin-treated diabetes, hypoglycemia was common but usually asymptomatic.

A trio of trials provide more evidence for the safety and efficacy of SPCs to lower blood pressure.

A meta-analysis finds a potential signal favoring anticoagulation for patent foramen ovale and mixed results for left atrial enlargement.

Patients in their 30s had higher rates of secondary hypertension than did younger adults, which highlights potential gaps in screening recommendations.